Cargando…
Epigenetic Therapies for Acute Myeloid Leukemia and Their Immune-Related Effects
Over the past decades, our molecular understanding of acute myeloid leukemia (AML) pathogenesis dramatically increased, thanks also to the advent of next-generation sequencing (NGS) technologies. Many of these findings, however, have not yet translated into new prognostic markers or rationales for t...
Autores principales: | Gambacorta, Valentina, Gnani, Daniela, Vago, Luca, Di Micco, Raffaella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797914/ https://www.ncbi.nlm.nih.gov/pubmed/31681756 http://dx.doi.org/10.3389/fcell.2019.00207 |
Ejemplares similares
-
The Anti-Leukemia Effect of Ascorbic Acid: From the Pro-Oxidant Potential to the Epigenetic Role in Acute Myeloid Leukemia
por: Travaglini, S., et al.
Publicado: (2022) -
Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and Relapse
por: Gambacorta, Valentina, et al.
Publicado: (2022) -
Epigenetic Priming in Childhood Acute Lymphoblastic Leukemia
por: Raboso-Gallego, Javier, et al.
Publicado: (2019) -
Identification of m6A-Related lncRNAs Associated With Prognoses and Immune Responses in Acute Myeloid Leukemia
por: Li, Ding, et al.
Publicado: (2021) -
The prognostic marker FLVCR2 associated with tumor progression and immune infiltration for acute myeloid leukemia
por: Su, Xiuhua, et al.
Publicado: (2022)